Garry Pairaudeau
Chief Tech/Sci/R&D Officer at Exscientia AI Ltd.
Garry Pairaudeau active positions
| Companies | Position | Start | End |
|---|---|---|---|
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01/11/2020 | - |
Career history of Garry Pairaudeau
Former positions of Garry Pairaudeau
| Companies | Position | Start | End |
|---|---|---|---|
| EXSCIENTIA PLC | Chief Tech/Sci/R&D Officer | 01/11/2020 | 30/06/2023 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2014 | 01/11/2020 |
Training of Garry Pairaudeau
| The University of Southampton | Doctorate Degree |
Statistics
International
| United Kingdom | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Private companies | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Garry Pairaudeau
- Experience
